Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$3,784,153
+$3,466,381 QoQ
Shares Held
14,900
+1046.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.28%
of 13F equity value
Holder Rank
#1,820
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 68%
Shared 0%
None 32%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PARADIGM ASSET MANAGEMENT CO LLC holds $12,808,040 across 10 Drug Manufacturers - General names. JNJ ranks #1 (29.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
14,900 | $3,784,153 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
16,700 | $2,109,878 | |
| 3 | ABBV |
AbbVie Inc.
|
7,300 | $1,836,972 | |
| 4 | MRK |
Merck & Co., Inc.
|
13,500 | $1,734,750 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
20,400 | $1,175,448 | |
| 6 | PFE |
Pfizer Inc
|
41,300 | $994,504 | |
| 7 | LLY |
ELI LILLY & Co
|
550 | $659,686 | |
| 8 | NVS |
Novartis AG
|
1,800 | $282,096 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,784,153 | 14,900 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $317,772 | 1,300 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $269,035 | 1,300 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $259,588 | 1,400 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $213,850 | 1,400 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $1,766,196 | 10,650 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,540,203 | 10,650 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $2,033,853 | 12,550 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $1,834,308 | 12,550 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,776,234 | 17,550 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,750,787 | 17,550 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,811,287 | 18,050 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $3,169,708 | 19,150 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,014,250 | 32,350 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $5,714,627 | 32,350 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,429,400 | 8,750 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,659,718 | 9,350 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $859,565 | 4,850 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $829,689 | 4,850 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $783,275 | 4,850 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $831,937 | 5,050 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $829,967 | 5,050 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $826,245 | 5,250 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,985,044 | 20,050 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,297,773 | 23,450 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $3,592,962 | 27,400 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||